ALZHEIMER’S DISEASE
BioGeron Inc. is committed to the discovery of a non-prescription supplement that can be used for the prevention or delay of the early stages of Alzheimer’s Disease (AD), which includes developing a treatment for Mild Cognitive Impairment (MCI) and other conditions generally associated with the final stages of memory loss.
Additionally, the company plans to release another six formulas within the next year under their LifeExtenz Plus product line. Formulas planned to be released include Healthy Heart, Memory Plus, Bone Health, Immunity Plus, and several others.